Wednesday, July 12, 2006
Ooooooh, Don't Count Your Chickens Before They Hatch!
Soros’ Biotech Bet Loses $11M Billionaire investor George Soros lost big on a bet that biotech company Valentis would successfully develop a breakthrough cardiovascular treatment. Yesterday, Burlingame, Calif.-based Valentis announced that a clinical trial of its main drug, VLTS 934, which was... Sign in
to see full entry.